Usefulness of Triiodothyronine Replacement Therapy in Patients With ST Elevation Myocardial Infarction and Borderline/Reduced Triiodothyronine Levels (from the THIRST Study).
Adult
Aged
Biomarkers
/ blood
Coronary Angiography
Dose-Response Relationship, Drug
Echocardiography
Female
Hormone Replacement Therapy
/ methods
Humans
Male
Middle Aged
Myocardial Contraction
/ drug effects
ST Elevation Myocardial Infarction
/ diagnosis
Thyroid Hormones
/ blood
Treatment Outcome
Triiodothyronine
/ administration & dosage
Ventricular Remodeling
Journal
The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277
Informations de publication
Date de publication:
15 03 2019
15 03 2019
Historique:
received:
15
10
2018
revised:
29
11
2018
accepted:
07
12
2018
pubmed:
15
1
2019
medline:
20
12
2019
entrez:
15
1
2019
Statut:
ppublish
Résumé
The aim of the study was to investigate whether TH replacement therapy is safe and impact infarct size, left ventricular (LV) volumes and function in patients with acute myocardial infarction (AMI) and low T3 syndrome (LT3S). Thirty-seven AMI/LT3S patients were randomly treated or untreated with liothyronine (T3) therapy (maximum dosage 15 mcg/m
Identifiants
pubmed: 30638544
pii: S0002-9149(18)32210-0
doi: 10.1016/j.amjcard.2018.12.020
pii:
doi:
Substances chimiques
Biomarkers
0
Thyroid Hormones
0
Triiodothyronine
06LU7C9H1V
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
905-912Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.